![]() > California's Direct Flow Medical has enrolled the first patient in its U.S. > InspireMD, a maker of embolic protection stents, has cut back on its Israeli manufacturing and hired a European distribution company. > Breast imaging outfit Delphinus Medical has locked down a $6 million term loan from GE Capital to get its SoftVue tomography system to market. > Germany's Activaero has forged a research collaboration deal with Italy's Chiesi Farmaceutici to jointly evaluate a drug/device combination product using Activaero's inhalation technology to develop a cystic fibrosis treatment. > Louisiana's Moirai Orthopaedics gained a CE mark for its new pyrocarbon implant knee replacement system, and the initial launch will take place in Australia and England. > First time premarket approvals for med tech companies are down 47% since 2012, and M&A activity is also on the decline for the broader industry, EvaluateMedTech concludes in a new report. ![]() commercial launch for its breast cancer prognostic Dx. Item | Follow CeQur closes $27M round to fund insulin delivery device. More from FierceDrugDelivery | Follow Endo Tools Therapeutics, a Belgian maker of obesity-treating devices, has hauled in $3.3 million to develop its technology. Surgical robots slammed in another study. Story | Follow FDA roadblock for Guided Therapeutics and its cervical scanner. Article | Follow is ramping up the U.S.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |